Using PET with (18)F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment

PURPOSE: Positron emission tomography (PET) imaging of brain amyloid load has been suggested as a core biomarker for Alzheimer’s disease (AD). The aim of this study was to test the feasibility of using PET imaging with (18)F-AV-45 (florbetapir) in a routine clinical environment to differentiate betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Camus, V., Payoux, P., Barré, L., Desgranges, B., Voisin, T., Tauber, C., La Joie, R., Tafani, M., Hommet, C., Chételat, G., Mondon, K., de La Sayette, V., Cottier, J. P., Beaufils, E., Ribeiro, M. J., Gissot, V., Vierron, E., Vercouillie, J., Vellas, B., Eustache, F., Guilloteau, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315642/
https://www.ncbi.nlm.nih.gov/pubmed/22252372
http://dx.doi.org/10.1007/s00259-011-2021-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315642/
https://www.ncbi.nlm.nih.gov/pubmed/22252372
http://dx.doi.org/10.1007/s00259-011-2021-8

Ejemplares similares